Importantly, mice with a whole-body genetic deletion of Endo180 have no overt phenotype (14, 15); however, when implanted with syngeneic tumor cells, they show impaired tumor progression and a reduction in viable CAFs (13). Here, MRC2 is linked to neoplasm.